Contineum Therapeutics Growth Metrics (2023-2025) | CTNM

Growth Metrics Jun2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin (QoQ) -508764.00
EBIT Margin (QoQ) -548191.00
EBT Margin (QoQ) -515888.00
Enterprise Value Growth (1y) -63.56%-61.75%19.74%14.73%
Enterprise Value (QoQ) 5.82%-85.45%2.17%4.28%6.86%7.98%-3.95%
FCF Margin (QoQ) -567524.00
Interest Coverage Ratio (QoQ) 703.74%
Net Margin (QoQ) -516034.00
Operating Margin (QoQ) -548191.00
Return on Assets Growth (1y) -32.005.008.00
Return on Assets (QoQ) -33.002.00-3.003.003.005.00
Return on Capital Employed (QoQ) -32.002.00-4.00
Return on Equity Growth (1y) 9.0030.008.00
Return on Equity (QoQ) -18.0028.00-4.003.004.006.00
Return on Invested Capital (QoQ) -39.0034.00
Return on Sales Growth (1y) -5205.00
Return on Sales (QoQ) -5160.00-7.00